TY  - CHAP
M1  - Book, Section
TI  - Screening for Lung Cancer
A1  - Fitzpatrick, Meghan E.
A1  - Prendergast, Niall T.
A1  - Rivera-Lebron, Belinda
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - Key  Clinical  Updates  in  Screening  for  Lung  CancerThe  USPSTF  updated  its  recommendation  for  low-dose  CT  screening.  Annual  low-dose  CT  screening  for  lung  cancer  is  recommended  for  those  at  high  risk;  with  high-risk  criteria  including  age  50-80  years,  at  least  a  20  pack-years  smoking  history,  and  either  current  smoking  or  quit  date  within  past  15  years.  Screening  should  be  stopped  once  15  years  have  elapsed  since  quitting  smoking,  or  if  a  comorbid  condition  renders  the  benefits  of  screening  null.  Simulation  models  developed  for  the  purposes  of  informing  this  recommendation  found  yearly  screening  with  this  parameters  to  be  the  most  efficient  in  reducing  lung-cancer  related  deaths,  although  more  false-positive  test  results  are  expected  compared  with  the  original  recommendation.Krist  AH  et  al.  JAMA.  [PMID:  33687470]  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193146188
ER  -